Related Experiment Videos
Penicillinase-producing gonococci in the Netherlands in 1981
The Journal of Antimicrobial Chemotherapy
|January 1, 1983
Summary
In 1981, penicillinase-producing Neisseria gonorrhoeae (PPNG) strains represented 10% of Dutch isolates. Shifts in PPNG plasmid patterns and varying antibiotic susceptibility highlight the need for ongoing surveillance and treatment guideline evaluation.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Neisseria gonorrhoeae is a significant cause of sexually transmitted infections.
- Penicillinase-producing Neisseria gonorrhoeae (PPNG) strains pose a treatment challenge due to antibiotic resistance.
- Monitoring the epidemiology of PPNG is crucial for effective public health interventions.
Purpose of the Study:
- To analyze the prevalence and plasmid patterns of PPNG strains in the Netherlands in 1981.
- To investigate the geographical distribution and origins of PPNG strains.
- To assess the antibiotic susceptibility profiles of PPNG strains in relation to their plasmid patterns.
Main Methods:
- Isolation and identification of Neisseria gonorrhoeae strains.
- Determination of PPNG strains through penicillinase production testing.
- Plasmid profiling analysis of PPNG isolates.
- Antibiotic susceptibility testing of PPNG strains.
Main Results:
- In 1981, 1180 PPNG strains were identified, constituting approximately 10% of all gonococcal isolates in the Netherlands.
- Significant shifts in predominant plasmid patterns were observed over a short period.
- Geographical variations in PPNG strain prevalence and patterns were noted between major cities, suggesting localized spread from diverse sources.
- Antibiotic susceptibility varied among PPNG strains, correlating with specific plasmid patterns.
Conclusions:
- The study underscores the dynamic nature of PPNG epidemiology in the Netherlands.
- Distinct plasmid patterns and antibiotic resistance profiles necessitate continuous surveillance of gonococcal infections.
- Regular re-evaluation of antimicrobial treatment guidelines is essential to combat evolving resistance.